Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Study Evaluating the Safety and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee

NCT04520607 is registered in ClinicalTrials.gov with Biosplice Therapeutics, Inc. as lead sponsor.

NCT NCT04520607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04520607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Study Evaluating the Safety and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee
Lead sponsor
Biosplice Therapeutics, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
August 25, 2020
Completion date
June 30, 2023
Enrollment
276 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee